Stockreport
Challenge of two Lantus patents commences [Seeking Alpha]
US:NYSE Investor Relations: sanofi.com/en/investors
PDF
Challenge of two Lantus patents commencesThe USPTO's Patent Trial and Appeal Board (PTAB) hasinstituted inter partes review of two U.S. patents owned by Sanofi (NYSE:SNY) covering Lantus (insulin glargine injection) 100 Units/mL.The patents are being challenged by Mylan N.V. (NASDAQ:MYL) who plans to market its own version of insulin glargine. Sanofi sued Mylan for patent infringement after the latter filed a marketing application with the FDA.According to IQVIA, the U.S. market is ~$7.7B.Both stocks are up a fraction premarket.Click to subscribe to real-time analytics on MYLNow read:Premarket analyst action - healthcare »
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | SNY | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
SNY alerts
SNY alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting SANOFI news events
Weekly update
A roundup of the hottest topics
SNY
NEWS
NEWS
- FDA accepts Sanofi Pasteur's marketing application for expanded use of flu vaccine [Seeking Alpha][Seeking Alpha]
- BRIEF-FDA Accepts For Review Sanofi's Supplemental Biologics License Application [Reuters][Reuters]
- FDA accepts for review Supplemental Biologics License Application for 0.5 mL dose of Fluzone® Quadrivalent (Influenza Vaccine) in children 6-35 months of age[PR Newswire]
- Boehringer's operating income up 20.7 percent on Sanofi deal [Reuters][Reuters]
- Sanofi R&D chief to retire in late June [Seeking Alpha][Seeking Alpha]
- More
SNY
SEC Filings
SEC Filings
- 4/24/18 - Form 6-K
- 4/18/18 - Form 6-K
- 4/3/18 - Form 6-K
- SNY's page on the SEC website
- More